ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Pharmacy PHA

FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R. 3839 - Drug Shortage Prevention Act of 2012 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 296 and H.R.2245 Preserving Access to Life-Saving Medication Act S. 373 Fair Prescription Drug Competition Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 2295 - Patient Safety and Generic Labeling Improvement Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); White House Office; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Bills named: H.R. 5651 (112th), S. 373 (112th), H.R. 6433 (112th), H.R. 3988 (112th), S. 296 (112th), H.R. 6160 (112th), S. 2295 (112th), S. 3187 (112th), H.R. 3839 (112th), S. 44 (112th), H.R. 4332 (112th), S. 1855 (112th), S. 1584 (112th), H.R. 3995 (112th), H.R. 2182 (112th), S. 1734 (112th), H.R. 3026 (112th), S. 2516 (112th), H.R. 2245 (112th)

Trade (domestic/foreign) TRD

Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

Contacted: U.S. Trade Representative (USTR); Congressional Budget Office (CBO); Office of Management & Budget (OMB); White House Office; Federal Trade Commission (FTC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); SENATE; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3497 - MODDERN Cures Act of 2011 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S. 27 Preserve Access to Affordable Generics Act S. 373 Fair Prescription Drug Competition Act S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 1882 - The Fair and Immediate Release of Generic Drugs Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); White House Office; Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 2182 (112th), S. 1734 (112th), H.R. 3988 (112th), H.R. 3995 (112th), H.R. 3497 (112th), H.R. 4332 (112th), S. 373 (112th), S. 2516 (112th), S. 1882 (112th), S. 27 (112th), H.R. 5651 (112th), S. 3187 (112th)

Medicare/Medicaid MMM

FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs H.R. 3342 - Affordable Medicines Utilization Act of 2011 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 1356 - Affordable Medicines Utilization Act of 2011 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011

Contacted: White House Office; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE; Congressional Budget Office (CBO); Food & Drug Administration (FDA); Commerce, Dept of (DOC)

Bills named: S. 2516 (112th), H.R. 3342 (112th), S. 44 (112th), H.R. 6433 (112th), H.R. 6160 (112th), H.R. 5651 (112th), S. 1356 (112th), S. 1855 (112th), S. 3187 (112th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY12 and FY13 Budget H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.J.RES.117 - Continuing Appropriations Resolution, 2013 H.RES.778 - Providing for consideration of the joint resolution (H.J. Res. 117) making continuing appropriations for fiscal year 2013 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Federal Trade Commission (FTC); Congressional Budget Office (CBO); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 5651 (112th), H.R. 3988 (112th), H.Res. 778 (112th), S. 3187 (112th), H.J.Res. 117 (112th), H.R. 6433 (112th), S. 2516 (112th)